Pseudomonas aeruginosa recombinant protein Vac11 as well as preparation method and application

A Pseudomonas aeruginosa, recombinant protein technology, applied in biochemical equipment and methods, recombinant DNA technology, chemical instruments and methods, etc., can solve the problems of Pseudomonas aeruginosa bacterial virulence reduction and other problems, and achieve good immune protection Effects, preservation of spatial conformation and immunogenicity, effects with simple steps

Active Publication Date: 2016-07-13
CHENGDU OLYMVAX BIOPHARM +1
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, the deletion of the AmpDh3 gene will lead to a significant decrease in the virulence of Pseudomonas aeruginosa bacteria (MoyaB, et al. AntimicrobAgentsChemother.2008)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pseudomonas aeruginosa recombinant protein Vac11 as well as preparation method and application
  • Pseudomonas aeruginosa recombinant protein Vac11 as well as preparation method and application
  • Pseudomonas aeruginosa recombinant protein Vac11 as well as preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1 Cloning of Vac11 Gene and Construction of Recombinant Plasmid pGEX-6P-2-Vac11

[0046] 1. According to the full-length gene sequence of AmpDh3 protein of Pseudomonas aeruginosa PA01, the bioinformatics software was used for structural analysis to determine the target gene fragment of Vac11 to be amplified.

[0047] 2. According to the analysis results, the PCR method was used to amplify the AmpDh3 target gene fragment from the PA01 genome, and the amplification steps were as follows:

[0048] 1) Design the PCR primers as follows, which are SEQ ID NO: 3-4 (the base sequence of the restriction site is underlined)

[0049]

[0050]

[0051] 2) Take out the preserved Pseudomonas aeruginosa strain PA01 from the freezer at -80°C and spread it on LB solid medium, culture it at 37°C overnight, then pick a single colony and inoculate it in LB liquid medium for 8 hours , referring to the bacterial genome extraction kit to extract the PA01 genome.

[0052] 3) P...

Embodiment 2

[0080] Example 2: Induced expression, purification and identification of expression form of recombinant fusion protein Vac11 in prokaryotic expression system-Escherichia coli

[0081] 1. Vac11 induced expression

[0082] Take 100 μL of the overnight cultured pGEX-6P-2-Vac11 / XL-1blue bacterial solution and add it to 10 mL of Amp+ resistant LB medium, culture overnight at 180 rpm at 37°C, take 400 μL of the overnight cultured bacterial solution and add it to 20 mL of Amp+ resistant LB medium (The rest of the bacterial solution is stored in a refrigerator at 4°C for later use), culture at 37°C for 2-3 hours, rotate at 200 rpm, and reactivate until the OD600 is 0.8-1.0, add 4 μL of IPTG to make the final concentration 200 μM, and place on a shaker Induced expression Induced expression at 30°C for 3h.

[0083] 2) Take out the bacterial solution after induced expression, centrifuge at 12000rpm for 5min, discard the supernatant, add 1mLlysisbuffer (20mMPB, pH7.2, 250mMNacl) to mix, ...

Embodiment 3

[0090] Embodiment 3: Preparation of Vac11 antigen

[0091] 1. Amplify culture to obtain protein

[0092] Take 400 μL of the spare pGEX-6P-2-Vac11 / XL-1blue bacterial solution stored in the 4°C refrigerator and add it to 20mL LB medium containing Amp resistance for one activation. After culturing at 200rpm for 5-6 hours at 37°C, take 8mL once The activated bacterial solution was added to 400mL LB medium containing Amp resistance for secondary activation, cultured at 37°C for 3-4h until the OD600 was 1.0, then added 80μLPTG (final concentration 200μM) and placed in a shaker at 16°C overnight to induce Finally, 12000rpm was centrifuged for 15min to collect the thalli, and after adding 20mLlysisbuffer (same as Example 2) to resuspend the thallus, the bacterium liquid was subjected to ultrasonic cracking for 3min (200V), and the supernatant was collected and 800 μL of GlutathioneSepharose4B (GE Company) gel beads (beads) binding treatment; then SDS-PAGE gel electrophoresis.

[009...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a pseudomonas aeruginosa recombinant protein Vac11 as well as a preparation method and an application. Animal tests prove that the recombinant protein can effectively stimulate organisms to carry out higher humoral immune response and give play to good immunoprotection effects, thus being beneficial to prevention, diagnosis and treatment of pseudomonas aeruginosa. The recombinant protein prepared by adopting the method provided by the invention has high expression quantity and is convenient to separate and purify.

Description

technical field [0001] The invention belongs to the field of biotechnology and pharmacy, and specifically relates to a recombinant protein Vac11 (AmpDh3) of Pseudomonas aeruginosa, and further relates to a preparation method and application of the recombinant protein. Background technique [0002] Pseudomonas aeruginosa (Pseudomonas aeruginosa, PA), commonly known as Pseudomonas aeruginosa, belongs to the genus Pseudomonas in non-fermenting bacteria. It is ubiquitous and is one of the most common opportunistic pathogens in clinical practice. At present, the bacterium has become one of the pathogenic bacteria with the highest isolation rate in ICU wards, burns, war trauma infections, and mechanical ventilation-associated pneumonia (VAP) worldwide. PA infection can occur in any part and tissue of the human body, such as burns or trauma, middle ear, cornea, urethra, and respiratory tract, etc., and can also cause systemic infections such as endocarditis, gastroenteritis, pneum...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C12N15/62C12N15/70C12N1/21G01N33/68G01N33/569A61K39/104A61P31/04C12R1/385
CPCA61K39/104A61K2039/54A61K2039/55505C07K2319/00C12N9/6489C12N15/62C12N15/70C12N2800/101C12Y304/24G01N33/56911G01N33/68G01N2333/21
Inventor 章金勇顾江邹全明杨峰杨茜赵莉群彭六生吴翼王逸麟
Owner CHENGDU OLYMVAX BIOPHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products